-
PurposeExpresses codon optimized SARS-CoV-2 NSP7, NSP8, and NSP12 in E. coli.
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 160540 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 * |
* Log in to view industry pricing.
Backbone
-
Vector backbonepQE-30 and pcI-ts,ind+
- Total vector size (bp) 9813
-
Modifications to backboneCmR gene from pQE-30 removed and AmpR from pcI-ts,ind+ removed.
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature30°C
-
Growth Strain(s)DH5alpha
-
Growth instructionsGrowth at 37 or addition of nalidixic acid induces expression of NSP7 and NSP8
-
Copy numberHigh Copy
Gene/Insert 1
-
Gene/Insert nameSARS-CoV-2 NSP7
-
Alt nameSevere acute respiratory syndrome coronavirus 2 non-structural protein 7
-
SpeciesSynthetic
-
Insert Size (bp)255
-
Entrez GeneORF1ab (a.k.a. GU280_gp01)
Gene/Insert 2
-
Gene/Insert nameSARS-CoV-2 NSP8
-
Alt nameSevere acute respiratory syndrome coronavirus 2 non-structural protein 8
-
SpeciesSynthetic
-
Insert Size (bp)600
-
Entrez GeneORF1ab (a.k.a. GU280_gp01)
Gene/Insert 3
-
Gene/Insert nameSARS-CoV-2 NSP12
-
Alt nameSevere acute respiratory syndrome coronavirus 2 non-structural protein 12
-
SpeciesSynthetic
-
Entrez GeneORF1ab (a.k.a. GU280_gp01)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byCodon optimized NSP7, NSP8, and NSP12 genes were from custom plasmids synthesized by Genscript.
-
Articles Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pQE-(NSP12)-pcI-ts,ind+-(NSP7-NSP8) was a gift from Kenneth Johnson (Addgene plasmid # 160540 ; http://n2t.net/addgene:160540 ; RRID:Addgene_160540) -
For your References section:
Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase. Dangerfield TL, Huang NZ, Johnson KA. iScience. 2020 Nov 28:101849. doi: 10.1016/j.isci.2020.101849. 10.1016/j.isci.2020.101849 PubMed 33283177